Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × Abiraterone Acetate × Clear all

NCT06193993 2024-01-08

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Phase 1 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms